Cargando…

P16-28. The first year: early correlates of long-term HIV progression

Detalles Bibliográficos
Autores principales:	Chattopadhyay, PK, Brodie, T, Ganesan, A, Mascola, JR, Michael, NL, Roederer, M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767756/ http://dx.doi.org/10.1186/1742-4690-6-S3-P257

Ejemplares similares

P14-10. Comparable immunogenicity of VRC DNA and rAd5 HIV-1 vaccines delivered by intramuscular, subcutaneous and intradermal routes in healthy adults (VRC 011)
por: Ledgerwood, JE, et al.
Publicado: (2009)

HIV-1 neutralizing antibodies display dual specificity for the primary and coreceptor binding sites and preferential recognition of fully-cleaved Env
por: Li, Y, et al.
Publicado: (2012)

P16-16. Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda
por: Kyosiimire-Lugemwa, J, et al.
Publicado: (2009)

HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals
por: van den Kerkhof, TL, et al.
Publicado: (2012)

P09-05. Mechanism of HIV-1 resistance to a monoclonal antibody that effectively targets the site of CD4 attachment
por: Wu, X, et al.
Publicado: (2009)

Programmed Death-1(PD-1), a correlate of protection against disease progression in HIV-1 infected long-term non-progressors
por: Kyosiimire-Lugemwa, J
Publicado: (2012)

P04-28. Breadth and magnitude of neutralizing antibody responses in subjects infected with HIV-1 subtype D or recombinants in Rakai district, Uganda
por: Eller, L, et al.
Publicado: (2009)

Structural definition for a new modality of broad and potent antibody neutralization at the CD4-binding site on HIV-1 gp120
por: Zhou, T, et al.
Publicado: (2012)

Isolation of broadly neutralizing HIV-1 antibodies from high-throughput single B cell culture
por: Longo, NS, et al.
Publicado: (2012)

P16-48. Immunologic and virologic characterization of an ART-treated HIV-1 patients cohort with long-term control of viremia
por: Kinloch, S, et al.
Publicado: (2009)

More than ten years without any detectable HIV viremia: exceptionally long-term non-progressive HIV infection
por: Manfredi, Roberto, et al.
Publicado: (2010)

P16-18. Regulatory T cell frequencies correlate with T cell activation in chronic HIV-1 infection
por: Angin, M, et al.
Publicado: (2009)

P16-31. Skewed HIV-1-specific CD4+ Th2 helper cell contribution in progressive HIV-1 infection
por: Chevalier, M, et al.
Publicado: (2009)

P17-27. Development of recombinant adenovirus 28 vectors for HIV vaccines
por: Ko, S, et al.
Publicado: (2009)

P19-57 LB. Gene-based vaccination protects against mucosal infection by a heterologous highly pathogenic SIV isolate in rhesus monkeys
por: Letvin, N, et al.
Publicado: (2009)

No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV
por: Fernández-Montero, JV, et al.
Publicado: (2010)

Characteristics of HIV-1 gp120 molecules that bind ancestor, intermediate and mature forms of VRC01-like antibodies
por: Joyce, M, et al.
Publicado: (2012)

P04-16. Orally exposed uninfected individuals have systemic anti-HIV response correlating with partner's viral load
por: Hasselrot, K, et al.
Publicado: (2009)

P10-12. Altered NK cell phenotype and function in Ugandans with chronic HIV-1 infection
por: Eller, MA, et al.
Publicado: (2009)

Structural definition of a novel CD4-induced epitope that is targeted by a single-headed immunoglobulin to effect broad and potent HIV neutralization
por: Acharya, P, et al.
Publicado: (2012)

Feasibility of testing antibodies to HIV from filter paper using HIV rapid test kits
por: Ganesan, A, et al.
Publicado: (2010)

High prevalence of the UGT1A1*28 variant in HIV-infected individuals in Greece
por: Panagopoulos, P, et al.
Publicado: (2010)

P19-28. The V3 region of HIV-1: from NMR to vaccine design
por: Moseri, A, et al.
Publicado: (2009)

HIV-1 acetylated integrase is targeted by KAP1 (TRIM28) to inhibit viral integration
por: Allouch, Awatef, et al.
Publicado: (2009)

P18-06. Increased HIV-specific immunity in HIV-infected individuals vaccinated with a DNA prime, rAd5 boost regimen
por: Casazza, JP, et al.
Publicado: (2009)

A Bayesian network approach to study host and viral genetic correlates of HIV-1 disease progression
por: Snoek, Joke, et al.
Publicado: (2011)

Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01
por: Lynch, RM, et al.
Publicado: (2012)

Long-term intrapatient evolution during HIV-2 infection
por: MacNeil, Adam, et al.
Publicado: (2006)

P17-09. Immunization with a single HIV-1 envelope sequence can generate CD8+ T lymphocytes capable of recognizing multiple variant forms of envelope
por: Hulot, SL, et al.
Publicado: (2009)

Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells
por: Vollbrecht, T, et al.
Publicado: (2012)

P15-28. Attitudes and awareness of HIV vaccine research in HIV uninfected MSM in four US cities: Rochester, Boston, San Francisco and Philadelphia
por: Alexander, SB, et al.
Publicado: (2009)

Increased differentiation associates with decreased polyfunctionality for HIV but not CMV-specific CD8+ T cell responses
por: Riou, C, et al.
Publicado: (2012)

Long-term plasticity determines the postsynaptic response to correlated afferents with multivesicular short-term synaptic depression
por: Bird, Alex D, et al.
Publicado: (2014)

P16-05. Upregulation of PD-1 and CTLA-4 on HIV-specific T cells in HIV-infected infants
por: Nqoko, BS, et al.
Publicado: (2009)

CCL28 induces mucosal homing of HIV-1-specific IgA-secreting plasma cells in mice immunized with HIV-1 Virus-like Particles
por: Rainone, V, et al.
Publicado: (2012)

P17-28 LB. The antiviral efficacy of HIV-specific CD8+ T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate
por: Ranasinghe, S, et al.
Publicado: (2009)

Anti-CD4-gp120 complex antibodies in long-term non-progressors HIV-1 positive patients: a role in slowing disease progression?
por: Burastero, Samuele, et al.
Publicado: (2006)

P20-21 LB. Gene-to-gene differences in evolutionary rate between HIV-1 and natural SIV from sooty mangabeys: implications for vaccine tests in non-human primates
por: Fischer, W, et al.
Publicado: (2009)

Priming with DNA encoding functional trimers and boosting with soluble trimeric protein elicited tier 2 neutralizing antibodies in non-human primates
por: Chakrabarti, BK, et al.
Publicado: (2012)

Trial steering committees for randomised controlled trials: updating and redeveloping guidance and terms of reference informed by current practice and experience
por: Conroy, EJ, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_uci1s129b9959uv366ddhhiaai